⌘K

Login Start Free

Home/Filings/4/0001562180-23-005448

4//SEC Filing

ANDO GORAN 4

Accession 0001562180-23-005448

CIK 0001314102other

View on SEC.gov Company Profile

Filed

Jun 21, 8:00 PM ET

Accepted

Jun 22, 9:19 AM ET

Size

7.5 KB

Accession

0001562180-23-005448

Insider Transaction Report

Form 4

Period: 2023-06-20

EyePoint Pharmaceuticals, Inc.EYPT

Director

Transactions

Award
Stock Option (Right to Buy)
2023-06-20+13,500→ 13,500 total
Exercise: $3.50From: 2024-02-23Exp: 2033-06-19→ Common Stock (13,500 underlying)
Award
Stock Option (Right to Buy)
2023-06-20+27,100→ 27,100 total
Exercise: $3.26From: 2024-01-06Exp: 2033-06-19→ Common Stock (27,100 underlying)

Documents

1 file

4
primarydocument.xmlPrimary
PRIMARY DOCUMENT

Issuer

EyePoint Pharmaceuticals, Inc.

CIK 0001314102

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001110748

Filing Metadata

Form type: 4
Filed: Jun 21, 8:00 PM ET
Accepted: Jun 22, 9:19 AM ET
Size: 7.5 KB

View on SEC.gov